These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6407278

  • 1. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
    Groot PH, Dijkhuis-Stoffelsma R, Grose WF, Ambagtsheer JJ, Fernandes J.
    Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
    [Abstract] [Full Text] [Related]

  • 2. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
    Weisweiler P, Merk W, Jacob B, Schwandt P.
    Eur J Clin Pharmacol; 1986 Jan; 30(2):191-4. PubMed ID: 3709644
    [Abstract] [Full Text] [Related]

  • 3. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
    Wakasugi T, Sakai T, Watanabe A, Tatami R, Ueda K, Ueda R, Kametani T, Haba T, Koizumi J, Miyamoto S, Mabuchi H, Takeda R, Sakai Y, Yoshimura A, Takegoshi T, Ohta M, Ono S, Ohka T, Takeshita H.
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
    [No Abstract] [Full Text] [Related]

  • 4. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB, Probstfield JL, Crow LO, Isaacson SO.
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [Abstract] [Full Text] [Related]

  • 5. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P.
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
    Schmidt EB, Illingworth DR, Bacon S, Mahley RW, Weisgraber KH.
    Atherosclerosis; 1993 Jan 25; 98(2):213-7. PubMed ID: 8457260
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ, Linden CV, O'Connell MJ, Heilman J.
    Arch Intern Med; 1982 Apr 25; 142(4):721-3. PubMed ID: 7073415
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR, Grundy SM.
    Metabolism; 1981 Feb 25; 30(2):123-8. PubMed ID: 7464561
    [Abstract] [Full Text] [Related]

  • 15. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L, Nowicka G, Szostak WB, Naruszewicz M.
    Atherosclerosis; 1987 Feb 25; 63(2-3):203-9. PubMed ID: 3827981
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH, Smith FR, Berns L, Eder HA, Goodman DS.
    Atherosclerosis; 1981 Apr 25; 39(1):35-43. PubMed ID: 7018502
    [Abstract] [Full Text] [Related]

  • 17. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 18. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
    Vega GL, East C, Grundy SM.
    Arteriosclerosis; 1989 Jul 01; 9(1 Suppl):I135-44. PubMed ID: 2912427
    [Abstract] [Full Text] [Related]

  • 19. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP, Helve E, Karjalainen K, Tarkkanen A, Tikkanen MJ.
    Atherosclerosis; 1990 May 01; 82(1-2):85-95. PubMed ID: 2360923
    [Abstract] [Full Text] [Related]

  • 20. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE, Illingworth DR.
    Proc Natl Acad Sci U S A; 1983 Dec 01; 80(24):7631-5. PubMed ID: 6584876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.